Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma

類似資料

• Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma.
  著者:: Quan Wang, 等
  出版事項: (2013-01-01)
• Retraction: Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of Colorectal Carcinoma.
  著者:: PLOS One Editors
  出版事項: (2025-01-01)
• Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
  著者:: Feldman, Morris E, 等
  出版事項: (2009)
• mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition
  著者:: Limon, Jose J., 等
  出版事項: (2014)
• mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity
  著者:: Kalim, Khalid W., 等
  出版事項: (2017)